Related Experiment Video
Updated: Jan 21, 2026

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
Published on: November 14, 2025
Dual-modality theranostics probes: sintegrative strategies for precision management of oncologic malignancies
Xilin Jing1,2,3, Yutao Li1,2,3, Yijing Zhang4
1Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
Abstract:
Cancer remains a formidable global public health challenge. Recent advancements in immunotherapy and targeted therapies have revolutionized diagnostic and therapeutic paradigms. Within this context, theranostics-an emerging field integrating molecular imaging with therapeutic interventions-has shown promise in achieving precision oncology. Central to theranostic platforms are dual-modality probes utilizing positron emission tomography, fluorescence, and magnetic resonance imaging technologies, which offer synergistic advantages such as complementary imaging modalities, intraoperative guidance, and real-time drug delivery monitoring. Despite growing research interest and early clinical trials, critical challenges persist in biosafety, metabolic stability, and imaging resolution. Structural optimization of probes and modality-specific selection based on cancer subtypes may address these limitations. This review systematically evaluates the design principles and clinical applications of dual-modality probes and proposes actionable strategies to enhance their translational potential.
Insights
Theranostics, integrating imaging and therapy, offers precision oncology through dual-modality probes. Further research into probe design and cancer-specific selection is crucial for clinical advancement.
Area of Science:
- Oncology
- Medical Imaging
- Nanotechnology
Background:
- Cancer presents a significant global health burden.
- Immunotherapy and targeted therapies have transformed cancer care.
- Theranostics merges molecular imaging and therapy for precision oncology.
Purpose of the Study:
- To review the design principles and clinical applications of dual-modality probes in theranostics.
- To identify challenges and propose strategies for enhancing the translational potential of these probes.
Main Methods:
- Systematic evaluation of dual-modality probes.
- Analysis of positron emission tomography, fluorescence, and magnetic resonance imaging technologies.
- Review of current research and early clinical trials.
Main Results:
- Dual-modality probes offer synergistic advantages like complementary imaging and real-time monitoring.
- Challenges include biosafety, metabolic stability, and imaging resolution.
- Structural optimization and cancer-subtype-specific selection are key.
Conclusions:
- Dual-modality probes are vital for advancing precision oncology.
- Addressing current limitations is essential for successful clinical translation.
- Further development is needed to fully realize the potential of theranostic probes.
Related Concept Videos
Sensory Modalities
General senses refer to the broad category of sensory information detected by receptors in the body and can be further grouped into somatic and visceral senses. Somatic sensations include touch, pressure, temperature, and pain and are essential for navigating our environment and...
Uncertainty in Measurement: Accuracy and Precision
Accuracy and Precision
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Persuasion Strategies

